The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Amino Acid Depletion Therapies: Starving Cancer Cells to Death
Open accessAbstract
Targeting tumor cell metabolism is an attractive form of therapy, as it may enhance treatment response in therapy resistant cancers as well as mitigate treatment-related toxicities by reducing the need for genotoxic agents. To meet their increased demand for biomass accumulation and energy production and to maintain redox homeostasis, tumor cells undergo profound changes in their metabolism. In addition to the diversion of glucose metabolism, this is achieved by upregulation of amino acid metabolism. Interfering with amino acid availability can be selectively lethal to tumor cells and has proven to be a cancer specific Achilles' heel. Here we review the biology behind such cancer specific amino acid dependencies and discuss how these vulnerabilities can be exploited to improve cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From Krebs to clinic: glutamine metabolism to cancer therapy
Altman, B. J., Stine, Z. E., & Dang, C. V. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.71 · Cited by 2,119
Cysteine depletion induces pancreatic tumor ferroptosis in mice
Badgley, M. A., Kremer, D. M., Maurer, H. C., DelGiorno, K. E., Lee, H.-J., Purohit, V., Sagalovskiy, I. R., Ma, A., Kapilian, J., Firl, C. E. M., et al. (2020) · Science · doi:10.1126/science.aaw9872 · Cited by 1,294
Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Leone, R. D., Zhao, L., Englert, J. M., Sun, I.-M., Oh, M.-H., Sun, I.-H., Arwood, M. L., Bettencourt, I. A., Patel, C. H., Wen, J., et al. (2019) · Science · doi:10.1126/science.aav2588 · Cited by 1,169 · cited 1×
“T cells upregulate their oxidative metabolism resulting in long-lived and highly activated T cells, whereas tumor cells fail to do so and eventually die [51].”
BackgroundPhosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
Locasale, J. W., Grassian, A. R., Melman, T., Lyssiotis, C. A., Mattaini, K. R., Bass, A. J., Heffron, G., Metallo, C. M., Muranen, T., Sharfi, H., et al. (2011) · Nature Genetics · doi:10.1038/ng.890 · Cited by 1,120
Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells
Maddocks, O. D. K., Berkers, C. R., Mason, S. M., Zheng, L., Blyth, K., Gottlieb, E., & Vousden, K. H. (2013) · Nature · doi:10.1038/nature11743 · Cited by 1,007
Targeting Metabolism for Cancer Therapy
Luengo, A., Gui, D. Y., & Vander Heiden, M. G. (2017) · Cell Chemical Biology · doi:10.1016/j.chembiol.2017.08.028 · Cited by 971 · cited 5×
“For example: PHGDH inhibitors suppress cancer cell proliferation in vitro and in patient-derived xenograft (PDX) models [20,36].”
BackgroundInfluentialGlutaminolysis: A Hallmark of Cancer Metabolism
Yang, L., Venneti, S., & Nagrath, D. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044546 · Cited by 859
The eIF2α kinases: their structures and functions
Donnelly, N., Gorman, A. M., Gupta, S., & Samali, A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1252-6 · Cited by 859
Lieu, E. L., Nguyen, T., Rhyne, S., & Kim, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0375-3 · Cited by 818
Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine
Zhang, J., Pavlova, N. N., & Thompson, C. B. (2017) · The EMBO Journal · doi:10.15252/embj.201696151 · Cited by 651 · cited 3×
“Increased Gln synthesis is often due to upregulation of Gln synthetase (GS) [15], whereas enhanced glutaminolysis is caused by increased GLS activity and correlates with poor prognosis in glioblastoma, ovarian cancer, breast cancer, medulloblastoma, and lung cancer [16,17].”
BackgroundCancer SLC43A2 alters T cell methionine metabolism and histone methylation
Bian, Y., Li, W., Kremer, D. M., Sajjakulnukit, P., Li, S., Crespo, J., Nwosu, Z. C., Zhang, L., Czerwonka, A., Pawłowska, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2682-1 · Cited by 642
Dietary methionine influences therapy in mouse cancer models and alters human metabolism
Gao, X., Sanderson, S. M., Dai, Z., Reid, M. A., Cooper, D. E., Lu, M., Richie, J. P., Ciccarella, A., Calcagnotto, A., Mikhael, P. G., et al. (2019) · Nature · doi:10.1038/s41586-019-1437-3 · Cited by 636
Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells
Wortel, I. M. N., van der Meer, L. T., Kilberg, M. S., & van Leeuwen, F. N. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.07.003 · Cited by 609
Self-citationMechanisms and Implications of Metabolic Heterogeneity in Cancer
Kim, J., & DeBerardinis, R. J. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.013 · Cited by 606
Modulating the therapeutic response of tumours to dietary serine and glycine starvation
Maddocks, O. D. K., Athineos, D., Cheung, E. C., Lee, P., Zhang, T., van den Broek, N. J. F., Mackay, G. M., Labuschagne, C. F., Gay, D., Kruiswijk, F., et al. (2017) · Nature · doi:10.1038/nature22056 · Cited by 603
L‐asparaginase treatment in acute lymphoblastic leukemia: A focus on Erwinia asparaginase
Pieters, R., Hunger, S. P., Boos, J., Rizzari, C., Silverman, L., Baruchel, A., Goekbuget, N., Schrappe, M., & Pui, C. (2011) · Cancer · doi:10.1002/cncr.25489 · Cited by 569
Methionine metabolism in health and cancer: a nexus of diet and precision medicine
Sanderson, S. M., Gao, X., Dai, Z., & Locasale, J. W. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0187-8 · Cited by 563
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
Schellekens, H. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80075-3 · Cited by 556
Cramer, S. L., Saha, A., Liu, J., Tadi, S., Tiziani, S., Yan, W., Triplett, K., Lamb, C., Alters, S. E., Rowlinson, S., et al. (2017) · Nature Medicine · doi:10.1038/nm.4232 · Cited by 538
Asparagine bioavailability governs metastasis in a model of breast cancer
Knott, S. R. V., Wagenblast, E., Khan, S., Kim, S. Y., Soto, M., Wagner, M., Turgeon, M.-O., Fish, L., Erard, N., Gable, A. L., et al. (2018) · Nature · doi:10.1038/nature25465 · Cited by 532
Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
Krall, A. S., Xu, S., Graeber, T. G., Braas, D., & Christofk, H. R. (2016) · Nature Communications · doi:10.1038/ncomms11457 · Cited by 504
Amino acid homeostasis and signalling in mammalian cells and organisms
Bröer, S., & Bröer, A. (2017) · Biochemical Journal · doi:10.1042/bcj20160822 · Cited by 502
New aspects of amino acid metabolism in cancer
Vettore, L., Westbrook, R. L., & Tennant, D. A. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0620-5 · Cited by 502
NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink
Ulanovskaya, O. A., Zuhl, A. M., & Cravatt, B. F. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1204 · Cited by 447
Cornerstones of CRISPR–Cas in drug discovery and therapy
Fellmann, C., Gowen, B. G., Lin, P.-C., Doudna, J. A., & Corn, J. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.238 · Cited by 443
The eEF2 Kinase Confers Resistance to Nutrient Deprivation by Blocking Translation Elongation
Leprivier, G., Remke, M., Rotblat, B., Dubuc, A., Mateo, A.-R. F., Kool, M., Agnihotri, S., El-Naggar, A., Yu, B., Prakash Somasekharan, S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.055 · Cited by 414
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Xiang, Y., Stine, Z. E., Xia, J., Lu, Y., O’Connor, R. S., Altman, B. J., Hsieh, A. L., Gouw, A. M., Thomas, A. G., Gao, P., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75836 · Cited by 409
Methionine is a metabolic dependency of tumor-initiating cells
Wang, Z., Yip, L. Y., Lee, J. H. J., Wu, Z., Chew, H. Y., Chong, P. K. W., Teo, C. C., Ang, H. Y.-K., Peh, K. L. E., Yuan, J., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0423-5 · Cited by 403
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy
Bertero, T., Oldham, W. M., Grasset, E. M., Bourget, I., Boulter, E., Pisano, S., Hofman, P., Bellvert, F., Meneguzzi, G., Bulavin, D. V., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.012 · Cited by 393
Jacque, N., Ronchetti, A. M., Larrue, C., Meunier, G., Birsen, R., Willems, L., Saland, E., Decroocq, J., Maciel, T. T., Lambert, M., et al. (2015) · Blood · doi:10.1182/blood-2015-01-621870 · Cited by 387
ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
Qing, G., Li, B., Vu, A., Skuli, N., Walton, Z. E., Liu, X., Mayes, P. A., Wise, D. R., Thompson, C. B., Maris, J. M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.021 · Cited by 375
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Zhang, W., Trachootham, D., Liu, J., Chen, G., Pelicano, H., Garcia-Prieto, C., Lu, W., Burger, J. A., Croce, C. M., Plunkett, W., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2432 · Cited by 357
As Extracellular Glutamine Levels Decline, Asparagine Becomes an Essential Amino Acid
Pavlova, N. N., Hui, S., Ghergurovich, J. M., Fan, J., Intlekofer, A. M., White, R. M., Rabinowitz, J. D., Thompson, C. B., & Zhang, J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.006 · Cited by 341
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase
Iwamoto, S., Mihara, K., Downing, J. R., Pui, C.-H., & Campana, D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30235 · Cited by 336
Histidine catabolism is a major determinant of methotrexate sensitivity
Kanarek, N., Keys, H. R., Cantor, J. R., Lewis, C. A., Chan, S. H., Kunchok, T., Abu-Remaileh, M., Freinkman, E., Schweitzer, L. D., & Sabatini, D. M. (2018) · Nature · doi:10.1038/s41586-018-0316-7 · Cited by 321
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo
Venneti, S., Dunphy, M. P., Zhang, H., Pitter, K. L., Zanzonico, P., Campos, C., Carlin, S. D., La Rocca, G., Lyashchenko, S., Ploessl, K., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1009 · Cited by 312
Sun, L., Song, L., Wan, Q., Wu, G., Li, X., Wang, Y., Wang, J., Liu, Z., Zhong, X., He, X., et al. (2015) · Cell Research · doi:10.1038/cr.2015.33 · Cited by 310
Asparagine synthetase: Function, structure, and role in disease
Lomelino, C. L., Andring, J. T., McKenna, R., & Kilberg, M. S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.819060 · Cited by 308
Amino Acids and Their Transporters in T Cell Immunity and Cancer Therapy
Wang, W., & Zou, W. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.09.006 · Cited by 298
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
Lee, J. S., Adler, L., Karathia, H., Carmel, N., Rabinovich, S., Auslander, N., Keshet, R., Stettner, N., Silberman, A., Agemy, L., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.019 · Cited by 296
Neurons release serine to support mRNA translation in pancreatic cancer
Banh, R. S., Biancur, D. E., Yamamoto, K., Sohn, A. S. W., Walters, B., Kuljanin, M., Gikandi, A., Wang, H., Mancias, J. D., Schneider, R. J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.016 · Cited by 292 · cited 1×
“Also, Ser-starved pancreatic ductal adenocarcinoma were shown to attract peripheral axons secreting Ser into the tumor [94] while in neuroblastoma, tumor associated macrophages release interleukin 1β and tumor necrosis factor α in response to Arg depletion, leading to upregulation of Arg2 in the neuroblastoma cells, c…”
The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer
Najumudeen, A. K., Ceteci, F., Fey, S. K., Hamm, G., Steven, R. T., Hall, H., Nikula, C. J., Dexter, A., Murta, T., Race, A. M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00753-3 · Cited by 289
Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition
Ngo, B., Kim, E., Osorio-Vasquez, V., Doll, S., Bustraan, S., Liang, R. J., Luengo, A., Davidson, S. M., Ali, A., Ferraro, G. B., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1228 · Cited by 272
Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth
Krall, A. S., Mullen, P. J., Surjono, F., Momcilovic, M., Schmid, E. W., Halbrook, C. J., Thambundit, A., Mittelman, S. D., Lyssiotis, C. A., Shackelford, D. B., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.02.001 · Cited by 266
Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment
Tanaka, K., Sasayama, T., Irino, Y., Takata, K., Nagashima, H., Satoh, N., Kyotani, K., Mizowaki, T., Imahori, T., Ejima, Y., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78239 · Cited by 239
Amino acid metabolism in hematologic malignancies and the era of targeted therapy
Tabe, Y., Lorenzi, P. L., & Konopleva, M. (2019) · Blood · doi:10.1182/blood.2019001034 · Cited by 237
Elgogary, A., Xu, Q., Poore, B., Alt, J., Zimmermann, S. C., Zhao, L., Fu, J., Chen, B., Xia, S., Liu, Y., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1611406113 · Cited by 234 · cited 1×
“To increase the half-life and reduce immunogenicity, therapeutic enzymes have been modified by conjugation to polyethylene glycol (PEG) [96], nanoparticle encapsulation [78], or erythrocyte encapsulation [97], and the treatment can be combined with immune-suppressive agents such as prednisone and dexamethasone.”
BackgroundTsai, W.-B., Aiba, I., Long, Y., Lin, H.-K., Feun, L., Savaraj, N., & Kuo, M. T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3605 · Cited by 233
Methods for High-throughput Drug Combination Screening and Synergy Scoring
He, L., Kulesskiy, E., Saarela, J., Turunen, L., Wennerberg, K., Aittokallio, T., & Tang, J. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7493-1_17 · Cited by 232
Gwinn, D. M., Lee, A. G., Briones-Martin-del-Campo, M., Conn, C. S., Simpson, D. R., Scott, A. I., Le, A., Cowan, T. M., Ruggero, D., & Sweet-Cordero, E. A. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.12.003 · Cited by 230
Cancer Metabolism: Current Understanding and Therapies
Counihan, J. L., Grossman, E. A., & Nomura, D. K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00775 · Cited by 226
Multiple amino acid sensing inputs to mTORC1
Shimobayashi, M., & Hall, M. N. (2016) · Cell Research · doi:10.1038/cr.2015.146 · Cited by 223
The Diverse Functions of Non-Essential Amino Acids in Cancer
Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213
Herranz, D., Ambesi-Impiombato, A., Sudderth, J., Sánchez-Martín, M., Belver, L., Tosello, V., Xu, L., Wendorff, A. A., Castillo, M., Haydu, J. E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3955 · Cited by 208
Gupta, S., Wang, C., Raetz, E. A., Schore, R., Salzer, W. L., Larsen, E. C., Maloney, K. W., Mattano, L. A., Carroll, W. L., Winick, N. J., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03024 · Cited by 191
Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase via Release of Glutamine
Ehsanipour, E. A., Sheng, X., Behan, J. W., Wang, X., Butturini, A., Avramis, V. I., & Mittelman, S. D. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4402 · Cited by 185
Bjornsti, M.-A., & Houghton, P. J. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.027 · Cited by 181
Scott, L., Lamb, J., Smith, S., & Wheatley, D. N. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1353 · Cited by 178
Kang, M. H., Kang, Y. H., Szymanska, B., Wilczynska-Kalak, U., Sheard, M. A., Harned, T. M., Lock, R. B., & Reynolds, C. P. (2007) · Blood · doi:10.1182/blood-2007-03-080325 · Cited by 178
Arginine—Dual roles as an onconutrient and immunonutrient
Albaugh, V. L., Pinzon‐Guzman, C., & Barbul, A. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24490 · Cited by 172
Drug-induced amino acid deprivation as strategy for cancer therapy
Fung, M. K. L., & Chan, G. C.-F. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0509-9 · Cited by 172
Targeting Glutamine Metabolism and Redox State for Leukemia Therapy
Gregory, M. A., Nemkov, T., Park, H. J., Zaberezhnyy, V., Gehrke, S., Adane, B., Jordan, C. T., Hansen, K. C., D’Alessandro, A., & DeGregori, J. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3223 · Cited by 171
One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy
Shuvalov, O., Petukhov, A., Daks, A., Fedorova, O., Vasileva, E., & Barlev, N. A. (2017) · Oncotarget · doi:10.18632/oncotarget.15053 · Cited by 168
Asparagine Synthetase in Cancer: Beyond Acute Lymphoblastic Leukemia
Chiu, M., Taurino, G., Bianchi, M. G., Kilberg, M. S., & Bussolati, O. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01480 · Cited by 168
Nakamura, A., Nambu, T., Ebara, S., Hasegawa, Y., Toyoshima, K., Tsuchiya, Y., Tomita, D., Fujimoto, J., Kurasawa, O., Takahara, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1805523115 · Cited by 164
Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target
Mussai, F., Egan, S., Higginbotham-Jones, J., Perry, T., Beggs, A., Odintsova, E., Loke, J., Pratt, G., U, K. P., Lo, A., et al. (2015) · Blood · doi:10.1182/blood-2014-09-600643 · Cited by 163
Kremer, J. C., Prudner, B. C., Lange, S. E. S., Bean, G. R., Schultze, M. B., Brashears, C. B., Radyk, M. D., Redlich, N., Tzeng, S.-C., Kami, K., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.077 · Cited by 159
Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II
Jones, C. L., Stevens, B. M., D’Alessandro, A., Culp-Hill, R., Reisz, J. A., Pei, S., Gustafson, A., Khan, N., DeGregori, J., Pollyea, D. A., et al. (2019) · Blood · doi:10.1182/blood.2019898114 · Cited by 158 · cited 2×
“For leukemia it was shown that mesenchymal stem cells (MSCs) in the bone marrow niche protect leukemic blasts from ASNase induced cytotoxicity [90], whereas bone marrow stromal cells provide Cys for CLL cells [91].”
BackgroundGlutamine Addiction and Therapeutic Strategies in Lung Cancer
Vanhove, K., Derveaux, E., Graulus, G., Mesotten, L., Thomeer, M., Noben, J., Guedens, W., & Adriaensens, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020252 · Cited by 142
Tan, Y., Sun, X., Xu, M., Tan, X., Sasson, A. R., Rashidi, B., Han, Q., Tan, X., Wang, X., An, Z. J., et al. (1999) · PubMed · Cited by 124
Long, Y., Tsai, W.-B., Wangpaichitr, M., Tsukamoto, T., Savaraj, N., Feun, L. G., & Kuo, M. T. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0302 · Cited by 121
Lee, Y.-M., Lee, G., Oh, T.-I., Kim, B. M., Shim, D.-W., Lee, K., Kim, Y. J., Lim, B. O., & Lim, J.-H. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3243 · Cited by 120
Strekalova, E., Malin, D., Good, D. M., & Cryns, V. L. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2792 · Cited by 115
Rinaldi, G., Pranzini, E., Elsen, J. V., Broekaert, D., Funk, C. M., Planque, M., Doglioni, G., Altea‐Manzano, P., Rossi, M., Geldhof, V., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.11.027 · Cited by 114
Epner, D. E., Morrow, S. R., Wilcox, M., & Houghton, J. L. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc422_2 · Cited by 111
Qie, S., Yoshida, A., Parnham, S. R., Oleinik, N. V., Beeson, G. C., Beeson, C., Öğretmen, B., Bass, A. J., Wong, K., Rustgi, A. K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09179-w · Cited by 108
Beyond the Warburg effect: How do cancer cells regulate one-carbon metabolism?
Rosenzweig, A., Blenis, J., & Gomes, A. P. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00090 · Cited by 107 · cited 1×
“Although tumor cell metabolism has long been recognized as a potential therapeutic target and antimetabolites such as methotrexate and 5-fluoruracil (5-FU) were successfully introduced as anticancer therapy decades ago [3,103], most of these compounds fail to discriminate between the tumor and rapidly dividing normal…”
Gabra, M. B. I., Yang, Y., Li, H., Senapati, P., Hanse, E. A., Lowman, X. H., Tran, T. Q., Zhang, L., Doan, L. T., Xu, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17181-w · Cited by 107
Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias
Hinze, L., Pfirrmann, M., Karim, S., Degar, J., McGuckin, C., Vinjamur, D. S., Sacher, J. R., Stevenson, K. E., Neuberg, D. S., Orellana, E. A., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.004 · Cited by 106
Methionine deprivation suppresses triple-negative breast cancer metastasisin vitroandin vivo
Jeon, H., Kim, J. H., Lee, E., Jang, Y. J., Kwon, J. Y., Kwon, J. Y., Kim, S., Kim, S., Park, J. H. Y., Kim, J.-E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11615 · Cited by 104
Bean, G. R., Kremer, J. C., Prudner, B. C., Schenone, A. D., Yao, J.-C., Schultze, M., Chen, D. Y., Tanas, M. R., Adkins, D. R., Bomalaski, J. S., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.232 · Cited by 103
Wang, Y., Zhang, J., Ren, S., Sun, D., Huang, H., Wang, H., Jin, Y., Li, F., Zheng, C., Liu, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.026 · Cited by 103
Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections
Fernandes, H. S., Teixeira, C. S. S., Fernandes, P. A., Ramos, M. J., & Cerqueira, N. M. F. S. A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1254194 · Cited by 99
Riess, C., Shokraie, F., Classen, C. F., Kreikemeyer, B., Fiedler, T., Junghanß, C., & Maletzki, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495382 · Cited by 95
Thewes, V., Simon, R., Hlevnjak, M., Schlotter, M., Schroeter, P., Schmidt, K. V., Wu, Y., Anzeneder, T., Wang, W., Windisch, P. Y., et al. (2017) · Oncogene · doi:10.1038/onc.2017.32 · Cited by 90
Exploiting methionine restriction for cancer treatment
Chaturvedi, S., Hoffman, R. M., & Bertino, J. R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.05.003 · Cited by 90
Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia
Gregory, M. A., Nemkov, T. G., Reisz, J. A., Zaberezhnyy, V., Hansen, K. C., D’Alessandro, A., & DeGregori, J. V. (2017) · Experimental Hematology · doi:10.1016/j.exphem.2017.09.007 · Cited by 88
ZBTB1 Regulates Asparagine Synthesis and Leukemia Cell Response to L-Asparaginase
Williams, R. T., Guarecuco, R., Gates, L. A., Barrows, D., Passarelli, M. C., Carey, B. W., Baudrier, L., Jeewajee, S. K. A., La, K., Prizer, B., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.008 · Cited by 84
Takahashi, H., Inoue, J., Sakaguchi, K., Takagi, M., Mizutani, S., & Inazawa, J. (2017) · Oncogene · doi:10.1038/onc.2017.59 · Cited by 82
Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma
Fultang, L., Gamble, L. D., Gneo, L., Berry, A. M., Egan, S. A., de Bie, F. J., Yogev, O., Eden, G. L., Booth, S., Brownhill, S. C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2139 · Cited by 73
Fiedler, T., Strauß, M., Hering, S., Redanz, U., William, D., Rosche, Y., Classen, C. F., Kreikemeyer, B., Linnebacher, M., & Maletzki, C. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1026478 · Cited by 63
Supplementation of l ‐arginine boosts the therapeutic efficacy of anticancer chemoimmunotherapy
Satoh, Y., Kotani, H., Iida, Y., Taniura, T., Notsu, Y., & Harada, M. (2020) · Cancer Science · doi:10.1111/cas.14490 · Cited by 62
Inhibition of Glutamine Synthetase Triggers Apoptosis in Asparaginase-Resistant Cells
Rotoli, B. M., Uggeri, J., Dall’Asta, V., Visigalli, R., Barilli, A., Gatti, R., Orlandini, G., Gazzola, G. C., & Bussolati, O. (2005) · Cellular Physiology and Biochemistry · doi:10.1159/000087238 · Cited by 56
Aldoss, I. T., & Forman, S. J. (2020) · Blood · doi:10.1182/blood.2019002132 · Cited by 48
Conti, L., Bolli, E., Lorenzo, A. D., Franceschi, V., Macchi, F., Riccardo, F., Ruiu, R., Russo, L., Quaglino, E., Donofrío, G., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0082 · Cited by 48
Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development
Salazar‐Fontana, L. I., Desai, D. D., Khan, T. A., Pillutla, R. C., Prior, S., Ramakrishnan, R., Schneider, J., & Joseph, A. M. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0030-z · Cited by 47
Erythrocyte Encapsulated L -Asparaginase (Graspa) in Acute Leukemia
Thomas, X., & Jeune, C. L. (2016) · International Journal of Hematologic Oncology · doi:10.2217/ijh-2016-0002 · Cited by 44
Rizzari, C., Lanvers‐Kaminsky, C., Valsecchi, M. G., Ballerini, A., Matteo, C., Gerß, J., Würthwein, G., Silvestri, D., Colombini, A., Conter, V., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.206433 · Cited by 44
Barve, A., Vega, A. A., Shah, P. P., Ghare, S. S., Casson, L. K., Wunderlich, M., Siskind, L. J., & Beverly, L. J. (2019) · Cells · doi:10.3390/cells8111322 · Cited by 36
Chien, W. W., Beux, C. L., Rachinel, N., Julien, M., Lacroix, C., Allas, S., Sahakian, P., Cornut-Thibaut, A., Lionnard, L., Kucharczak, J., et al. (2015) · Scientific Reports · doi:10.1038/srep08068 · Cited by 33
Cited by
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Tufail, M., Jiang, C.-H., & Li, N. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02119-3 · Cited by 534
RNA modifications in physiology and disease: towards clinical applications
Delaunay, S., Helm, M., & Frye, M. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-023-00645-2 · Cited by 345
Amino acid metabolism in tumor biology and therapy
Chen, J., Cui, L., Lu, S., & Xu, S. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06435-w · Cited by 255
Xu, M., Fei, J., Xiao, Z.-X., & Yi, Y. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025106 · Cited by 2
Metadata
- Authors
- Butler, M., van der Meer, L. T., & van Leeuwen, F. N.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 32
- Issue
- 6
- Pages
- 367-381
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W3142100769
- Cited by
- 268
- References
- 100
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.